The pathobiological consequences of myelin-specific immunoglobulins generated by this population of B-cells may be of great significance during the epitope spreading effects of EAE-induced neurodegeneration and by extension MS, raising the possibility of novel B-cell therapeutics targeting NgR1 and NgR3. Here, RTN4RL1 is linked to myeloid sarcoma.